Company Name

Principal Name * *Directors / Signatories / KMP / Principals

CLINIGENE INTERNATIONAL LIMITED

As on: 27-Aug-2019

Company Status: amalgamated

Place Company Investigation

View Public Document

Paid-up Capital(INR)

500,000

Authorised Capital(INR)

5,000,000

CIN.

U85195KA2000PLC027566

ROC Code

RoC-Bangalore

Date of Incorporation

04/08/2000

D&B D-U-N-S® Number

91-XXX-8532

Company Category

Company limited by Shares

Company SubCategory

Non-govt company

Class of Company

Public

Industry

SERVICES

Authorised Capital( INR)

5,000,000

Paid up Capital( INR)

500,000

Number of Members

Registered Address

Clinigene House, Tower I, Semicon Park, Phase-II, Electronics City, Hosur Road, Bangalore Bangalore KA 560100 IN

Email Id

kiran.kumar@biocon.com

Whether Listed or not

Unlisted

Last AGM

23/07/2014

Last Balance Sheet

31/03/2014

Registration Number

27566

Potentially Related Company Based on Common Directorship

Company Name	Common Directors
BIOCON LIMITED	3
BIOCON BIOPHARMACEUTICALS LIMITED	3
BIOCON BIOSPHERE LIMITED	2
SYNGENE INTERNATIONAL LIMITED	2
MAZUMDAR SHAW MEDICAL FOUNDATION	2
BIOCON PHARMA LIMITED	2
BIOCON RESEARCH LIMITED	2
BIOCON SYNGENE ACADEMY	2
GLENLOCH PROPERTIES LLP	2
IMMUNEEL THERAPEUTICS PRIVATE LIMITED	1
INFOSYS LIMITED	1
INVEST KARNATAKA FORUM	1
NARAYANA HRUDAYALAYA LIMITED	1
NARAYANA VAISHNO DEVI SPECIALTY HOSPITALS PRIVATE LIMITED	1
SCIENCE GALLERY BENGALURU	1
UNITED BREWERIES LIMITED	1
BIOCON BIOLOGICS INDIA LIMITED	1

Report Type Price
Quick Check Report INR 2500.00 /- Report Status : Available Financial Year : N/A Add To Cart Buy Report View Sample Report
Basic Report INR 6000.00 /- Report Status : Available Financial Year : N/A Add To Cart Buy Report View Sample Report
Compliance Report INR 14000.00 /- Report Status : Available Financial Year : N/A Add To Cart Buy Report View Sample Report
Sectoral Risk Outlook (Industry Report) Sectoral Risk Outlook (Industry Report) Status : Unavailable Financial Year : NA View Sample Report

No. of search on company

Total Searches: 30

News

Altasciences To Acquire Preclinical Safety Testing Services
-Clinical Leader

15-Aug-2018

Clinigene Launches a Best-in-class Biomarker Assay for Measuring "ABCA1 Specific Cholesterol Efflux"
-PR Newswire

09-Jun-2014

Business of interest

Registered address

Charges

Charge Holder Name	Assets under charge	Charge Amount	Date of Creation	Date of Modification	Status

Total Charges(INR)

Open Charges(INR)

Principals

Identification Number	Principal Names	Begin date	End date
00109213	RAVI RASENDRA MAZUMDAR	20/03/2007	17/08/2020
00347229	KIRAN MAZUMDAR SHAW	04/08/2000	29/09/2020
00347250	JOHN MCCALLUM MARSHALL SHAW	04/08/2000	29/09/2020
01553650	CHINAPPA MUCKATIRA BHEMAIAH	07/03/2013	-